HSIC HENRY SCHEIN INC

HSIC financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1000228 Exchange: Nasdaq SIC: 5047 (Wholesale-Medical, Dental & Hospital Equipment & Supplies)
Showing 3 of 18 annual and 0 of 68 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$8.89B (Jun 2025)
Industry (SIC)
5047 Wholesale-Medical, Dental & Hospital Equipment & Supplies
Incorporated
DE
Fiscal Year End
December (1226)
Phone
6318435500
EIN
113136595
Headquarters
MELVILLE, NY, 11747
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: SCHEIN HENRY INC (1996–2006)

▼ Key Metrics (TTM)

As of Jun 27, 2026
Financials
Revenue
$13.60B
Net Income
$403.00M
Total Assets
$11.38B
Total Equity
$3.82B
Total Debt
-
Free Cash Flow
$569.00M
Ratios
Gross Margin
31.3%
Operating Margin
5%
Net Margin
3%
Return on Equity
10.6%
Return on Assets
3.5%
Current Ratio
1.32x
FCF / Assets
5%

▼ FY 2025 Summary Analysis

Annual report ending Dec 27, 2025

Overview and Growth

In fiscal 2025, HENRY SCHEIN INC recorded $13.18B of revenue, net income of $398.00M, and an operating cash inflow of $712.00M. At $13.18B, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. The top line expanded 4.0% from $12.67B in fiscal 2024, increasing the company’s operating scale. Diluted earnings per share were $3.27, translating the period’s attributable earnings into the amount reported for each diluted share. The per-share result recorded a 7.2% increase from fiscal 2024 diluted EPS of $3.05. At period end, total assets were $11.21B, framing the scale of the company’s operating and financing commitments. Revenue equaled 1.18x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $4.11B, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 31.1% of revenue, showing how much of the top line remained after direct costs. Operations produced $653.00M of income after the reported operating expense base, before the remaining non-operating and tax effects. Relative to revenue, operating income represented 5.0%, showing how efficiently sales converted into operating profit. The bottom-line result was net income of $398.00M, after the operating, financing, tax, and other items recognized for the period. The final earnings result represented 3.0% of revenue, connecting the absolute net income figure with the company’s top-line scale. The company recognized $126.00M of income tax for the period, completing the transition from pretax income to net income. The relationship between net income and period-end equity was 10.2%, indicating the profitability achieved on book capital. Return on period-end assets was 3.5%, connecting net income with the company’s total asset base.

Liquidity and Capital Structure

Total assets were $11.21B, supported by $6.42B of liabilities and $3.90B of shareholder equity. The near-term balance sheet paired $4.46B of current assets with $3.23B of current liabilities at the reporting date. At 1.38x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $156.00M, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 4.8%, excluding receivables and other current assets. Relative to total assets, liabilities measured 57.3%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 1.4%, comparing reported cash and equivalents with the full positive asset balance. Total assets were 9.8% higher than fiscal 2024 assets of $10.22B, measuring the company’s own balance-sheet change. Against $4.03B of equity in fiscal 2024, the current book-equity balance moved 3.3% and ended lower. Cash and equivalents were 27.9% higher than fiscal 2024 cash of $122.00M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $712.00M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. The operating-cash-flow-to-net-income relationship was 1.79x, comparing cash generated by operations with the bottom-line earnings result. Capital spending was $139.00M, absorbing part of the cash generated from operations before free cash flow. Capital spending absorbed 19.5% of operating cash flow, quantifying the share of cash from operations directed to investment. The combination of operating cash flow and capital spending produced $573.00M of positive free cash flow for the period. Free cash flow represented 4.3% of revenue, linking post-investment cash generation with the company’s operating scale. Free cash flow equaled 5.1% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 27, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for HENRY SCHEIN INC
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $13.18B $12.67B $12.34B
Cost of Revenue $9.08B $8.66B $8.48B
Gross Profit $4.11B $4.02B $3.86B
OPERATING EXPENSES
SG&A Expense $3.08B $3.03B $2.96B
Operating Income $653.00M $621.00M $615.00M
NON-OPERATING INCOME / EXPENSE
Interest Expense $150.00M $131.00M $87.00M
Interest Income $33.00M $24.00M $17.00M
Other Income/Expense $-3.00M $-1.00M $-3.00M
Income Tax $126.00M $128.00M $120.00M
Net Income $398.00M $390.00M $416.00M
PER SHARE & SUPPLEMENTAL
Diluted EPS $3.27 $3.05 $3.16
Diluted Shares 121.72M 127.78M 131.75M
EBITDA $916.00M $872.00M $824.00M
Depreciation & Amortization $263.00M $251.00M $209.00M
Balance Sheet
ASSETS
Cash & Equivalents $156.00M $122.00M $171.00M
Accounts Receivable $1.65B $1.48B $1.86B
Inventory $2.00B $1.81B $1.82B
Other Current Assets $655.00M $569.00M $639.00M
Current Assets $4.46B $3.98B $4.49B
PP&E (Net) $621.00M $531.00M $498.00M
Goodwill $4.21B $3.89B $3.88B
Intangible Assets $1.02B $1.02B $916.00M
Other Noncurrent Assets (derived) $899.00M $794.00M $796.00M
Noncurrent Assets $6.75B $6.24B $6.09B
Total Assets $11.22B $10.22B $10.57B
LIABILITIES
Accounts Payable $1.15B $962.00M $1.02B
Short-term Debt $764.00M $650.00M $264.00M
Other Current Liabilities $680.00M $618.00M $700.00M
Current Liabilities $3.23B $2.80B $2.68B
Other Noncurrent Liabilities $486.00M $387.00M $436.00M
Noncurrent Liabilities $3.19B $2.58B $2.74B
Total Liabilities $6.42B $5.38B $5.42B
EQUITY
Common Stock $1.00M $1.00M $1.00M
Additional Paid-in Capital $177.00M $0 $0
Retained Earnings $3.29B $3.77B $3.86B
Accumulated OCI $-226.00M $-379.00M $-206.00M
Total Equity $3.90B $4.03B $4.29B
Redeemable NCI $895.00M $806.00M $864.00M
Total Liabilities & Equity $11.22B $10.22B $10.57B
SUPPLEMENTAL
Shares Outstanding 115.77M 124.16M 129.25M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $712.00M $848.00M $500.00M
Capital Expenditures $139.00M $148.00M $147.00M
Cash from Investing $-400.00M $-430.00M $-1.14B
Cash from Financing $-188.00M $-510.00M $701.00M
Free Cash Flow $573.00M $700.00M $353.00M
Beginning Cash (CFS) $122.00M $171.00M -
Net Change in Cash $124.00M $-92.00M -
Effect of FX on Cash $-90.00M $43.00M $-12.00M
Calculated Ending Cash $156.00M $122.00M -
Cash per BS $156.00M $122.00M $171.00M
Cash scope difference (CFS − BS) - - -
Cash per CFS $156.00M $122.00M $171.00M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is HENRY SCHEIN INC's annual revenue?

HENRY SCHEIN INC reported $13.60B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is HENRY SCHEIN INC profitable?

Yes. HENRY SCHEIN INC reported $403.00M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does HENRY SCHEIN INC generate free cash flow?

Yes. Free cash flow was $569.00M for trailing twelve months. Operating cash flow was $700.00M.

Related Companies

Wholesale-Medical, Dental & Hospital Equipment & Supplies